Medical societies call for ‘ALARA+’ safety standard to reduce radiation and injury risks in fluoroscopy labs
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Jun-2026 22:15 ET (24-Jun-2026 02:15 GMT/UTC)
WASHINGTON—Nine leading medical societies are calling for updated safety standards in fluoroscopy laboratories, often called “cath labs,” where clinicians performing minimally invasive procedures face radiation exposure and orthopedic injuries from heavy protective equipment. A report published simultaneously today in JSCAI, Heart Rhythm, JVIR, and JVS–Vascular Insights details the health, financial, and workforce impacts of fluoroscopy-guided settings and proposes an enhanced safety framework: ALARA+, or “As Low and As Light as Reasonably Achievable.”
The report addresses the dual occupational hazards linked to fluoroscopic procedures—radiation exposure and orthopedic strain from traditional protective equipment—and aims to ensure that safety is built into the environment, equipment, and standard of care.
A trial testing new treatments aimed at restoring warning signs of low blood glucose in people with type 1 diabetes who can no longer perceive when their blood sugars dip dangerously low is underway.
TCF3::HLF-positive B cell acute lymphoblastic leukemia is a rare and highly aggressive childhood cancer that causes severe damage to bones through mechanisms that remain unclear. To tackle this gap, researchers from Japan have developed a new mouse model that closely mirrors the disease as seen in humans. With it, they uncovered an inflammatory feedback loop that accelerates leukemia growth and bone destruction, highlighting a potential therapeutic target to combat disease progression and protect bone health.